Jan 22 (Reuters) - Athenex Inc:
* ATHENEX ANNOUNCES ENCOURAGING EARLY CLINICAL EFFICACY AND SAFETY DATA OF ORAXOL IN CLINICAL TRIAL FOR THE TREATMENT OF BREAST CANCER
* ATHENEX - ‍AMONG FIRST 12 EVALUABLE PATIENTS, 50% HAD PARTIAL RESPONSE, 50% HAD STABLE DISEASE IN TRIAL OF ORAXOL FOR TREATMENT OF BREAST CANCER​ Source text for Eikon: Further company coverage:
 